Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Tumor-Agnostic 1Genitourinary 1

Conditions

Neoplasms 1

Interventions

pembrolizumab 12Specimen Handling 8Biopsy 8Magnetic Resonance Spectroscopy 7Paclitaxel 6trastuzumab deruxtecan 4Fluorouracil 4Bevacizumab 4durvalumab 3Pemetrexed 3Oxaliplatin 3Leucovorin 3Exercise 3Cetuximab 3Carboplatin 3Capecitabine 3Blood Specimen Collection 3trametinib 2olaparib 2nilotinib 2dostarlimab 2cabozantinib 2X-Rays 2Temozolomide 2Standard of Care 2Radiosurgery 2Nivolumab 2Irinotecan 2Cisplatin 2zolbetuximab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Artificial Intelligence × Tumor-Agnostic × 30 days × Clear all
NCT06909643 2026-06-03

Development and Validation of a Multimodal Fusion Artificial Intelligence Model for Predicting the Efficacy of Neoadjuvant Treatment of Bladder Cancer

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Completed
469 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡